Completed PHASE2 INTERVENTIONAL 15-arm NCT01437735

Dose Finding Study for QAW039 in Asthma

A Randomized, Placebo-controlled, Dose-ranging, Multi-centre Trial of QAW039 (1-450 mg p.o.), to Investigate the Effect on FEV1 and ACQ in Patients With Moderate-to-severe, Persistent, Allergic Asthma, Inadequately Controlled With ICS Therapy.

Sponsor: Novartis Pharmaceuticals

Conditions Asthma

Interventions Montelukast Placebo QAW039

Updated 9 times since 2017 Last updated: Dec 11, 2020 Started: Aug 31, 2011 Primary completion: Nov 30, 2013 Completion: Nov 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Asthma and is currently completed. Novartis Pharmaceuticals leads this study, which shows 9 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Dec 2020 — Jan 2021 [monthly]

Completed PHASE2
Jun 2018 — Dec 2020 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Novartis Pharmaceuticals

Data source: Novartis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ahmedabad, India , Almelo, Netherlands , Antigua Guatemala, Guatemala , Arad, Romania , Armenia, Colombia , Asahikawa, Japan , Athens, Greece , Balassagyarmat, Hungary , Bangalore, India , Bangor, United States and 167 more locations